Clinical trial
The Effect of MK0633 in Patients With Chronic Asthma (0633-007)
NCT00404313 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00404313 |
|---|---|
| Title | The Effect of MK0633 in Patients With Chronic Asthma (0633-007) |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study of MK0633 in Adult Patients With Chronic Asthma |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | MK0633, Comparator: placebo |
| Enrollment | 688 |
| Start date | Jan 1, 2008 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 28, 2006 |
| Last update posted | Oct 20, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: